Search Tag: low molecular weight heparin
2014 07 Nov
A research team from the University of British Columbia has set out on making the use of heparin much safer by developing a universal antidote. Heparin, a lifesaving blood thinner that is used in major surgeries and treatment of heart disease, often requires an antidote to reverse its action and prevent serious bleeding issues in major surgical...Read more
2014 01 Nov
According to a study published in JAMA, prevention of venous thromboembolism (VTE) with low-molecular-weight heparin (LMWH) dalteparin in critically ill patients was more effective and had similar or lower costsĀ compared to unfractionated heparin (UFH). The study is to be presented at the Critical Care Canada Forum. The PROTECT trial compared the...Read more